These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38602289)

  • 1. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma.
    Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M
    Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.
    He X; Zhang Z; Li M; Li S; Ren L; Zhu H; Xiao B; Shi R
    BMC Cancer; 2015 Aug; 15():575. PubMed ID: 26245343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2.
    Liu L; Guo B; Han Y; Xu S; Liu S
    Clin Transl Oncol; 2022 Jul; 24(7):1311-1321. PubMed ID: 35122633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of PHLPP phosphatases in the nervous system.
    Mallick A; Sharma M; Dey CS
    Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
    Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
    Xiong X; Li X; Wen YA; Gao T
    J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
    Ishibashi O; Akagi I; Ogawa Y; Inui T
    Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of survival signalling pathways by the phosphatase PHLPP.
    O'Neill AK; Niederst MJ; Newton AC
    FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
    Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
    Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
    J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
    Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
    Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHLPP Signaling in Immune Cells.
    Lordén G; Lam AJ; Levings MK; Newton AC
    Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.